Jun Qi
Impact in
- Molecular Biology top 0.1%
- Protein Degradation and Inhibitors
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
- Chromatin Remodeling and Cancer
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
Papers in
-
- Protein Degradation and Inhibitors 77
- Chromatin Remodeling and Cancer 25
- Epigenetics and DNA Methylation 14
- Genomics and Chromatin Dynamics 14
- Histone Deacetylase Inhibitors Research 12
- Hematology 27
- Acute Myeloid Leukemia Research 10
- Multiple Myeloma Research and Treatments 8
- Co-authors
- James E. Bradner (70 shared papers)Andrew L. Kung (13 shared papers)Junwei Shi (4 shared papers)Christopher R. Vakoc (2 shared papers)Scott J. Rodig (7 shared papers)Scott C. Kogan (1 shared paper)Christopher Johns (1 shared paper)Katharina Blatt (1 shared paper)
- Journals
- Blood (25 papers)Cancer Discovery (10 papers)Cancer Cell (9 papers)Nature Communications (8 papers)Cancer Research (6 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Jun Qi
177 papers receiving 20.9k citations
Jun Qi's Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Biology 13.5k
- Genetics 1k
- Hematology 1.5k
- Cancer Research 1.1k
- Oncology 1.8k
Countries citing papers authored by Jun Qi
This map shows the geographic impact of Jun Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Qi more than expected).
Fields of papers citing papers by Jun Qi
This network shows the impact of papers produced by Jun Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Qi. The network helps show where Jun Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selective inhibition of BET bromodomains Hit paper breakdown → | 2010 | 3546 |
| 2 | BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc Hit paper breakdown → | 2011 | 2419 |
| 3 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1587 |
| 4 | R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling Hit paper breakdown → | 2017 | 941 |
| 5 | The dTAG system for immediate and target-specific protein degradation Hit paper breakdown → | 2018 | 797 |
| 6 | Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma Hit paper breakdown → | 2013 | 626 |
| 7 | Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer Hit paper breakdown → | 2016 | 538 |
| 8 | Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition Hit paper breakdown → | 2013 | 536 |
| 9 | 2012 | 343 | |
| 10 | 2013 | 336 | |
| 11 | 2012 | 328 | |
| 12 | 2013 | 289 | |
| 13 | 2017 | 284 | |
| 14 | 2014 | 266 | |
| 15 | 2012 | 252 | |
| 16 | 2016 | 248 | |
| 17 | 2017 | 240 | |
| 18 | 2015 | 237 | |
| 19 | 2013 | 225 | |
| 20 | 2018 | 196 |
About Jun Qi
Jun Qi is a scholar working on Molecular Biology, Hematology, Genetics, Oncology and Neurology, having authored 183 papers that have together received 21.2k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (77 papers), Chromatin Remodeling and Cancer (25 papers), Epigenetics and DNA Methylation (14 papers), Genomics and Chromatin Dynamics (14 papers), Histone Deacetylase Inhibitors Research (12 papers), Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). The work is most often cited by research in Molecular Biology (13.5k citations), Genetics (1k citations), Hematology (1.5k citations), Cancer Research (1.1k citations) and Oncology (1.8k citations). Jun Qi has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include James E. Bradner, Andrew L. Kung, Junwei Shi, Christopher R. Vakoc, Scott J. Rodig, Scott C. Kogan, Christopher Johns, Katharina Blatt, Edward Allan R. Sison and Meredith J. Taylor. Their work appears in journals such as Blood, Cancer Discovery, Cancer Cell, Nature Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.